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Introduction. Recurrent or persistent macular holes (MHs) are rare today due to the tendency to carefully peel the internal limiting
membrane. Conversely, their treatment is still a challenge for a vitreoretinal surgeon. Materials and Methods. &is is a retro-
spective, consecutive, and nonrandomized study of patients affected by recurrent or persistent MHs treated using small-gauge
pars plana vitrectomy (25- or 23-gauge) and an autologous ILM plug, at the Eye Clinic of Azienda Ospedaliera Universitaria
Careggi (Florence, Italy) between January 2016 and May 2018. We included 8 eyes of 8 patients in the study. Five patients had a
recurrent MH while 3 had a persistent MH. &e case series includes patients with myopic eyes and with large macular holes
(>400 μ). Patients were followed up with ophthalmoscopic examinations and swept-source optical coherence tomography (SS-
OCT). Results. &e mean age of the patients was 74 years (±4.81 standard deviation (SD)), 3 patients were men and 5 women. &e
average axial length was 26.28mm (±2.84 SD). Four patients had an AL≧ 26mm.&e mean MH diameter was 436.5 (±49.82 SD).
Average preoperative best-corrected visual acuity (BCVA) was 0.81 logMAR (±0.16 SD) and 20/125 Snellen. &e ILM plug has
been found integrated in the MH in all the follow-ups. Conclusion. In our study, an ILM autologous macular transplant was used
successfully in 5 cases of macular hole recurrence and 3 cases of macular hole persistence. &e anatomical success was achieved in
all the cases; 4 patients improved their BCVA, and 4 patients maintained it. Nomacular alterations such as RPE or retinal atrophy/
dystrophy were observed after 6months.
1. Introduction
Via pars plana (VPP) vitrectomy surgery for macular holes
(MHs) has a high success rate, with recent reports of primary
closure rates of more than 90% [1, 2]. Treatment of primary
macular holes is mainly performed with macular peeling
[3–7] or with inverted internal limiting membrane (ILM)
flap [4, 6, 8–12], if the patient has a large hole or has high
myopia. Unfortunately, macular holes can be persistent if
they remain open after surgery, or recurrent if they reopen
after initial closure. Previous studies showed an incidence of
MH persistence or reopening after initial closure between
4.8% and 9.2% [13–16]. &is may be due to residual epi-
retinal traction, insufficient gas tamponade, poor compli-
ance by the patient in keeping a prone position, or an
unknown cause [17]. Recurrent or persistent MH treatment
is still a challenge for a vitreoretinal surgeon.
A technique of autologous ILM plug transplantation has
already been proposed [18, 19].
&is work aims at reporting the anatomical and func-
tional results in a series of patients affected by recurrent
or persistent MH treated using an autologous ILM plug
transplant.
2. Materials and Methods
&is is a retrospective, consecutive, nonrandomized, and
comparative study of patients affected by recurrent or
persistent MHs treated using small-gauge pars plana vit-
rectomy (PPV) (25- or 23-gauge) and an autologous ILM
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plug at the Eye Clinic of Azienda Ospedaliera Universitaria
Careggi (Florence, Italy) between January 2016 and May
2018. We included 8 eyes of 8 patients in the study (Table 1).
Five patients had a recurrentMHwhile 3 had a persistent
MH.
All the patients were pseudophakic and had previously
undergone pars plana vitrectomy with macular ILM peeling
for a macular hole. &e average time for reopening of the
MH (5 eyes) was 15. 4months.
&e mean age of the patients was 74 years (±4.81 stan-
dard deviation (SD)); 3 patients were men and 5 women.&e
average axial length was 26.28mm (±2.84 SD). Four patients
had an AL≧ 26mm. &e mean MH diameter was 436.5
(±49.82 SD).
Average preoperative best-corrected visual acuity
(BCVA) was 0.81 logMAR (±0.16 SD) and 20/125 Snellen.
&e patients had previously undergone surgery in different
centers (3 patients in our centre by 3 different surgeons and 5
patients in different Italian centers all by different surgeons).
&e study was approved by the Institutional Ethics Com-
mittee and complied with the Declaration of Helsinki.
Written informed consent for participation was obtained
from all patients. All the patients underwent a complete
ophthalmologic examination, and optical coherence to-
mography (OCT) (SPECTRALIS; Heidelberg Engineering,
Germany; RS300 Advance SD-OCT; Nidek Co, Ltd, Japan;
and DRI OCT Triton OCT, Topcon, Japan) was conducted at
the time of surgery and 1month, 4months, and 6months
later.
&e macular hole minimum and maximum widths were
measured using a foveal OCT scan, as described by Duker
et al. [20]. Both widths are measured using the OCTcalliper
function, as a line drawn roughly parallel to the RPE.
Visual acuity was converted into logMAR to perform the
statistical analysis.
2.1. Surgical Technique. A standard 3-port 23/25-gauge
PPV was carried out (CONSTELLATION, Alcon Surgi-
cal, Fort Worth, TX). &e choice of the calibre of the
vitrector was made according to the axial length (AL) of
the eye; the 23-gauge was used for eyes with an
AL ≧ 28mm. An ILM dye Brilliant Blue G (Brilliant Peel,
Fluoron, Germany) or Membrane Blue Dual (DORC, the
Netherlands) was injected onto the ILM withdrawing area
to stain the ILM for approximately 30 seconds. All the
residual epiretinal membranes (ERMs), which were
present in 2 patients, were removed. &e ILM was har-
vested in an area inside the vascular arcades, starting from
the edge of the previously removed ILM, in a circular
fashion for approximately 1 disk diameter, and inserted
into the hole (see Video, Supplemental Digital Content 1).
A balanced salt solution and air exchange was performed,
and gas (C3F8 14% or SF6 20%) was injected at the end of
surgery. &e patients were subsequently kept in a face-
down position overnight and were advised to take a prone
position for 3 days after surgery. Topical therapy with
tobramycin and dexamethasone drops was carried out
after surgery for 30 days.
3. Results
Mean postoperative BCVA after 6months was 0.68 logMAR
(±0.14 SD) and 20/100 Snellen. &e ILM plug was kept in
place in all the cases and integrated in the MH to close it (see
Figure 1). No eyes had postoperative macular degeneration
such as RPE or retinal atrophy/dystrophy after 6months. All
8 patients had successfully closed holes at 6months and
improved their BCVA (4 cases) or maintained it (4 cases).
&e myopic patients also had encouraging visual outcomes,
which could be due to a preoperative absence of myopic
patchy macular atrophy.
4. Discussion
&e study shows 5 cases of recurrent MH and 3 cases of
persistent MH who underwent VPP combined with autol-
ogous ILM plug transplant into the macular hole. &e an-
atomical success was achieved in all the cases, and no cases of
postoperative macular degeneration such as RPE or retinal
atrophy/dystrophy were observed after 6months.
&is technique has already been described in the liter-
ature and has provided excellent results with success rates of
91–100% [21–26].
Concerning the inserting technique, the authors have
tried to solve the problem of autologous ILM transplant
instability within theMH in several ways. For example, some
authors have used ocular viscoelastic devices (OVD) to
stabilise the ILM flap [21, 23]. Morizane et al. [21] injected
OVD over the ILM flap to position it in the hole and hold it
in place. Dai et al. [23] instead used OVD to slightly lift the
edge of the recurrent hole and prepare it to receive the ILM
flap. Park et al. [22] used a drop of perfluoro-n-octane which,
after stabilising the ILM flap inside the macular hole, was
removed using a basic salt solution- (BSS-) air exchange.
We were able to insert the ILM flap without OVD or
perfluoro-n-octane. &e ILM flap floats into the vitreous
cavity and can be easily lost during manipulation. We re-
duced the infusion to 10mmHg to make the ILM plug easier
to manoeuvre and avoid excessive flotation. &e insertion of
the plug must be carried out with great care to avoid
damaging the macular edges. &e thinness and the motility
of the ILM plug allow good visualisation during the insertion
manoeuvres, and the contact with themacular surface can be
avoided (see supplemental digital content 1).
Risk factors for macular hole reopening include cataract
surgery, intraoperative retinal tears, and cystoid macular
oedema [27, 28]. High myopia is also a risk factor, and our
series confirms that 4 out of 8 eyes (50%) had an axial
length≧ 26mm.
All the patients had undergone phacoemulsification
during the first vitrectomy; therefore, in our series, re-
currence is independent of the lens removal. &e patho-
physiology causing the recurrence of the macular hole is not
clear but probably relates to mechanical factors, in-
flammatory factors, or both [15, 29].
Previous studies reported that the average reopening
time of a macular hole is between 12 and 15months [30, 31];
although in 1 series, an average reopening time of 28months
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was observed [32]. We found a result more similar to the
literature, because in our series, the reopening time in the
eyes with recurrent MHs was 14.6months. Surgical tech-
nological advances, and especially small-gauge surgery and
modern phacoemulsification, have led to decreased rates of
macular hole reopening. In fact, the decreased postoperative
inflammation that could cause a cystoid macular edema
possibly reduces the macular hole reopening rates. More-
over, better surgical instrumentation and the assistance of
vital dyes to identify ERMs and ILMs can help the surgeon to
perform a more thorough peeling.
A longer reopening time is probably related to more
consistent and improved ILM peeling. Better staining and
visualisation methods and better surgical instruments are
permitting more extensive and less traumatic macular
peeling. Internal limiting membrane peeling is thought to
reduce the recurrence rate of ERMs after macular surgery by
eliminating a scaffold for cellular reproliferation [13, 33, 34].
In fact, ERMs may create a “spillover” effect from the gliosis
that induced the macular hole to close after the first oper-
ation. &e “spillover” effect derives from tangential traction
that acts centrifugally and could counterbalance the cen-
tripetal forces that close a macular hole.
Histopathologic studies of ERMs associated with recurrent
holes have shown Muller cells and astrocyte cells similar to
those seen proliferating inside successfully closed holes [35, 36].
&ese cells could generate the extracellularmatrix and therefore
the centrifugal forces that reopen the macular hole.
In our series, ILM peeling had previously been per-
formed in all cases, but in 2 cases, we had to remove, during
the second operation, an ERM that had formed even in the
presence of ILM peeling. Each eye that had additional ERM
peeling during the second operation had successful macular
hole closure. Moreover, residual ERM can increase foveal
fluid, and if there is a noncomplete outer retinal layers
postoperative reconstruction, we can have a failure in the
RPE pump and then an increased risk of hole reopening due
to an uncontrolled cystic accumulation.
Chakrabaarti and Roufail [37] used the same shorter-
acting gas tamponade (SF6) without posturing instructions
with reasonable success rates in traumatic MHs. We also
used SF6, but we preferred to tell patients to stay face down
to facilitate closure in these complex recurrent or persistent
MHs cases. Gases are thought to increase the contact be-
tween the neurosensory retina and the RPE pump and
therefore reduce cystic macular accumulation.
Other tamponading tools, such as “heavy” silicone oils,
have been successfully proposed by Rizzo et al. [38–40] for
the closure of persistent holes. In our series, we preferred to
use a gas tamponade because we believe that a strong
tamponading force in the first postoperative period is crucial
for surgical success. Moreover, we do not have to remove the
silicone oil, risking MH reopening. Injecting silicone oil may
cause inflammation and emulsion; so, we only use it if
multiple peripheral retinal tears could lead to the formation
of a rhegmatogenous retinal detachment.
(a) (b)
(c) (d)
Figure 1: (a) Preoperative OCT that shows a recurrent macular hole (max. MH diameter 461). (b) 1month after the operation, the plug is
positioned into the closed macular hole. (c) 4months after the operation. (d) 6months after the operation. We can observe a partial
reconstruction of the outer retinal layers.


































1 75 461 Recurrent 24.7 20/200 1 20/200 1 18 Yes
2 69 385 Persistent 24.2 20/100 0.7 20/100 0.7 0 No
3 81 376 Recurrent 25.1 20/125 0.8 20/80 0.6 19 Yes
4 77 440 Recurrent 23.9 20/200 1 20/80 0.6 12 Yes
5 73 420 Recurrent 27.1 20/200 1 20/100 0.7 11 No
6 68 510 Persistent 28.4 20/100 0.7 20/100 0.7 0 No
7 79 485 Recurrent 27.8 20/80 0.6 20/63 0.5 17 No
8 70 415 Persistent 29.1 20/100 0.7 20/100 0.7 0 No
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Chakrabarti et al. [41] only used sterile air for the
postoperative tamponading of the MHs, but we have pre-
ferred gas in order to have a more prolonged effect.
&e frequencies of bilateral MHs among the reopened
cases in earlier studies were between 33% and 59%
[15, 42, 43]. In our cases, similarly, 3 out of 8 patients had
had a macular hole in the fellow eye. Patients with recurrent
holes may tend to form ERMs and tractional forces in
general that cause macular holes to open.
By analysing microstructural changes in the fovea
using swept-source optical coherence tomography (SS-
OCT) in eyes with large refractory MH following autol-
ogous ILM transplantation, Pires et al. [24] showed that
the closure was associated with the prolonged pro-
liferation of glial tissues in the fovea with fibrotic and
depigmentation phenomena. Moreover, Ra and Lee [44]
also described these phenomena.
In our study, conversely, we found good recovery of the
outer retinal layers, (see Figure 1) which they had already
been correlated positively with postoperative visual im-
provement [45]. Once the external limiting membrane
(ELM) is damaged, the breaching of the seal between the
neurosensory retina and the RPE pump causes fluid ac-
cumulation in the fovea with an elevation of the edges of
the hole and, consequently, its progression and
enlargement.
When the hole is successfully repaired, the migration of
the glial cells bridges the hole and reestablishes the seal
between the neurosensory retina and the RPE.&is allows a
fluid reduction in the cystic retina and therefore the
macular hole closure [46].
&e myopic patients had stable or improved visual
outcomes, which may be due to a preoperative absence of
myopic patchy macular atrophy. Moreover, we did not
observe macular pigment epithelium atrophy in myopic
patients after surgery. Concerning the hydrostatic theory of
macular hole closure [46], the presence of the ILM plug
could possibly reduce the entering of fluids into the retinal
layers of the macula.
&e limitations of this study are its retrospective nature,
the small number of patients, and short-term follow-up. A
prospective study and a more extensive series of cases using
this technique could provide reliable and conclusive data
on the efficacy of ILM autologous plugs and gas endo-
tamponade in recurrent/persistent macular holes.
5. Conclusion
In our study, an ILM autologous macular transplant revealed
its usefulness and safety in the cases of recurrent and per-
sistent macular holes that had previously undergone surgery
with vitrectomy and ILM macular peeling.
Data Availability
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cluded within the article.
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